Showing results (31-40 of 72) with videos related to

Sort By:
Pageof 8
Respiratory Research|March 29, 2025
Describing the burden of moderate exacerbations in patients with asthma from the Extended Salford Lung Study (Ext-SLS): a retrospective cohort studyEmma Goodall, Kieran J Rothnie, Beade Numbere, et al.
ERJ Open Research|November 14, 2019
Clinical effectiveness of once-daily fluticasone furoate/umeclidinium/vilanterol in usual practice: the COPD INTREPID study designSally Worsley, Neil Snowise, David M G Halpin, et al.
Respiratory Research|December 21, 2024
Assessing the comparative effects of interventions in COPD: a tutorial on network meta-analysis for cliniciansKatrin Haeussler, Afisi S Ismaila, Mia Malmenäs, et al.
Respiratory Research|October 29, 2021
Efficacy of umeclidinium/vilanterol according to the degree of reversibility of airflow limitation at screening: a post hoc analysis of the EMAX trialClaus F Vogelmeier, Paul W Jones, Edward M Kerwin, et al.
Advances in Therapy|August 4, 2021
Efficacy and Safety of Umeclidinium/Vilanterol in Current and Former Smokers with COPD: A Prespecified Analysis of The EMAX TrialLeif H Bjermer, Isabelle H Boucot, Claus F Vogelmeier, et al.
COPD|February 29, 2024
Understanding the Gaps in the Reporting of COPD Exacerbations by Patients: A ReviewPaul Jones, Ashraf Alzaabi, Alejandro Casas Herrera, et al.
ERJ Open Research|June 24, 2026
Cardiovascular events in patients with COPD after long-acting bronchodilator initiationDave Singh, Ana R Sousa, David E Newby, et al.
American Journal of Respiratory and Critical Care Medicine|December 16, 2024
Is Disease Stability an Attainable Chronic Obstructive Pulmonary Disease Treatment Goal?Dave Singh, MeiLan K Han, Surya P Bhatt, et al.
Advances in Therapy|November 3, 2017
Comparative Efficacy of Once-Daily Umeclidinium/Vilanterol and Tiotropium/Olodaterol Therapy in Symptomatic Chronic Obstructive Pulmonary Disease: A Randomized StudyGregory J Feldman, Ana R Sousa, David A Lipson, et al.
International Journal of Chronic Obstructive Pulmonary Disease|August 14, 2024
Evaluation of Adherence and Persistence to Triple Therapy in Patients with COPD: A German Claims Data StudyClaus F Vogelmeier, Kai-Michael Beeh, Michael Schultze, et al.
Pageof 8